This inventor holds 1 USPTO granted patent. Top assignees: Prostemics Co. Ltd., Seoul National University. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2012
Title: In-Soo Yoon: Innovator in Hyaluronic Acid Technology
Introduction
In-Soo Yoon is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biomedical engineering, particularly in the development of innovative materials for cell delivery systems. His work focuses on enhancing the effectiveness of therapeutic applications through advanced material science.
Latest Patents
In-Soo Yoon holds a patent for the "Preparation method of porous hyaluronic acid sponge for cell delivery system." This patent outlines a method that includes dissolving hyaluronic acid in an aqueous sodium hydroxide solution, adding an epoxy-based crosslinking agent, and homogenizing the solution. The process further involves hydrogelating the solution, washing it with ultrapure water, swelling it to achieve porosity, and freeze-drying to obtain a porous sponge. This invention is crucial for improving cell delivery mechanisms in medical treatments.
Career Highlights
Throughout his career, In-Soo Yoon has worked with esteemed institutions such as Seoul National University and Prostemics Co. Ltd. His experience in these organizations has allowed him to refine his expertise in material science and its applications in healthcare.
Collaborations
In his professional journey, In-Soo Yoon has collaborated with notable colleagues, including Jong-Hyuk Sung and Chung-Wook Chung. These partnerships have contributed to the advancement of research and innovation in their respective fields.
Conclusion
In-Soo Yoon's contributions to the development of porous hyaluronic acid sponges represent a significant advancement in biomedical engineering. His innovative approach to material preparation has the potential to enhance cell delivery systems, paving the way for improved therapeutic outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile